frenhaessw

Clinical trials begin for 2 Covid-19 vaccines developed in Nigeria

Nigeria has begun clinical trials for the two covid-19 vaccines developed in the country.

05 Avr 2021    
Nigeria President Muhammadu Buhari Receives his first dose of the Oxford/AstraZeneca Covid-19 vaccine at the presidential villa in Abuja, on March 6, 2021.   Nigeria President Muhammadu Buhari Receives his first dose of the Oxford/AstraZeneca Covid-19 vaccine at the presidential villa in Abuja, on March 6, 2021. - Copyright © africanews KOLA SULAIMON/AFP or licensors

Chairman of the presidential task force on covid-19, Boss Mustapha told reporters last week that the vaccines will be used after the completion of trials and obtaining of relevant certification.

The vaccines were developed by Nigerian scientists, and described as a scientific breakthrough which will ‘’ boost the morale and image of the medical industry in the country’’.

Mustapha asked all relevant agencies to provide the necessary support for the smooth running of the remaining protocols for the certification of the vaccines.

So far Africa’s most populous nation has taken delivery of 4 million doses of the Oxford-Astrazeneca vaccines from the Covax initiative. The country plans to receive 16 million doses.

Earlier this year, the Federal government announced that it had pumped some $25 million to develop local vaccines to battle the coronavirus.

As at the time of filing this report, Nigeria has recorded 163,000 coronvarius cases, 152,000 have recovered and some 2,058 covid-19 related deaths have been registered.

 Source: Africanews

 

Afrique Media TVLe monde c'est nous.

Tweets afm

Newsletter

Recevez par mail les dernières actualtités

  • Les articles à la une
  • L'actualité du monde

Nos Contacts

Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.
 +237 690887878
 +240 555898682
 +235 92521741